HELX vs. CNCR

Last updated Jun 5, 2026

HELX (Franklin Genomic Advancements ETF) and CNCR (Loncar Cancer Immunotherapy ETF) are both Health & Biotech Equities funds. HELX is actively managed, while CNCR is passively managed. HELX charges 0.50%/yr vs 0.79%/yr for CNCR.

Performance

HELX vs. CNCR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Franklin Genomic Advancements ETF (HELX) and Loncar Cancer Immunotherapy ETF (CNCR). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

HELX

• 1D: 3.11%
• 1M: 5.81%
• YTD: -1.55%
• 6M: -4.90%
• 1Y: 33.84%
• 3Y*: 5.75%
• 5Y*: -3.93%
• 10Y*: —

CNCR

• 1D: 0.00%
• 1M: 0.00%
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

HELX vs. CNCR - Yearly Performance Comparison

	2026 (YTD)
HELX Franklin Genomic Advancements ETF	2.01%
CNCR Loncar Cancer Immunotherapy ETF	0.00%

HELX vs. CNCR - Sectors Allocation Comparison

Sectors	HELX	CNCR
Healthcare	96.5%	96.6%
Basic Materials	2.7%	-
Technology	0.9%	-
Communication Services	-	-
Consumer Cyclical	-	-
Consumer Defensive	-	-
Energy	-	-
Financial Services	-	3.3%
Industrials	-	-
Real Estate	-	-
Utilities	-	-

Return for Risk

HELX vs. CNCR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HELX

HELX Risk / Return Rank: 42
HELX Sharpe Ratio Rank: 47
HELX Sortino Ratio Rank: 48
HELX Omega Ratio Rank: 44
HELX Calmar Ratio Rank: 39
HELX Martin Ratio Rank: 33

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

HELX vs. CNCR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Franklin Genomic Advancements ETF (HELX) and Loncar Cancer Immunotherapy ETF (CNCR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	HELX	CNCR	Difference
Sharpe ratio: Return per unit of total volatility	1.61	—	—
Sortino ratio: Return per unit of downside risk	2.32	—	—
Omega ratio: Gain probability vs. loss probability	1.28	—	—
Calmar ratio: Return relative to maximum drawdown	1.89	—	—
Martin ratio: Return relative to average drawdown	4.88	—	—
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

Sharpe Ratios by Period

	HELX	CNCR	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.61	—	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.16	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.25	—	—

Drawdowns

HELX vs. CNCR - Drawdown Comparison

The maximum HELX drawdown since its inception was -58.75%, which is greater than CNCR's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for HELX and CNCR.

Drawdown Indicators

	HELX	CNCR	Difference
Max Drawdown Largest peak-to-trough decline	-58.75%	0.00%	-58.75%
Max Drawdown (1Y) Largest decline over 1 year	-18.01%	—	—
Max Drawdown (3Y) Largest decline over 3 years	-29.48%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-58.75%	—	—
Current Drawdown Current decline from peak	-38.22%	0.00%	-38.22%
Average Drawdown Average peak-to-trough decline	-34.32%	0.00%	-34.32%
Ulcer Index Depth and duration of drawdowns from previous peaks	6.95%	—	—

Volatility

Volatility by Period

	HELX	CNCR	Difference
Volatility (1M) Calculated over the trailing 1-month period	7.45%	—	—
Volatility (6M) Calculated over the trailing 6-month period	16.47%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	21.07%	0.00%	+21.07%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	24.15%	0.00%	+24.15%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	27.41%	0.00%	+27.41%

HELX vs. CNCR - Expense Ratio Comparison

HELX has a 0.50% expense ratio, which is lower than CNCR's 0.79% expense ratio.

Dividends

HELX vs. CNCR - Dividend Comparison

HELX's dividend yield for the trailing twelve months is around 0.40%, while CNCR has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020
CNCR Loncar Cancer Immunotherapy ETF	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
HELX Franklin Genomic Advancements ETF	0.40%	0.39%	0.00%	0.00%	0.00%	0.24%	0.12%

Frequently Asked Questions

Which ETF is better, HELX or CNCR?

On fees, HELX is cheaper at 0.50% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, HELX or CNCR?

HELX is cheaper with a 0.50% expense ratio, compared with 0.79% for CNCR.

Which ETF pays a higher dividend yield, HELX or CNCR?

HELX has the higher dividend yield at 0.40%, compared with 0.00% for CNCR.

What is the main difference between HELX and CNCR?

They also come from different issuers: Franklin Templeton and Exchange Traded Concepts. Their fees differ too: 0.50% for HELX and 0.79% for CNCR.